CADTH Canadian Drug Expert Committee Recommendation: Cysteamine Delayed-Release (Procysbi — Horizon Pharma Ireland Ltd.): Indication: Nephropathic cystinosis [Internet]
Review
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jan.
CADTH Common Drug Reviews.
PMID:
30457789
Bookshelf ID:
NBK533470
No abstract available
Copyright © 2018 Canadian Agency for Drugs and Technologies in Health.
Publication types
Review
Grants and funding
Funding:
CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.